3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a commonly consumed recreational drug. As is the case with most secondary amines, MDMA reacts with formaldehyde under acidic conditions to form tertiary amines. This reaction is likely to occur in formalin-fixed tissue. In formalin solutions, MDMA is methylated producing 3,4-methylenedioxy-N,N-dimethylamphetamine (MDDA). MDDA standard was synthesized by treating methylenedioxyamphetamine HCI in formaldehyde solution. Structure confirmation was by electrospray ionization-mass spectrometry (MS) and MS-MS. Randomly chosen human liver pieces (100-200 rag) were injected with 2 pg of MDMA HCI. The liver pieces in centrifuge tubes were covered with 200 pL of formalin solution (20% v/v), held at room temperature for 24 h, and then homogenized. The resulting suspension was sonicated for 5 rain and then centrifuged. Controls consisted of substitution of 200 pL of water in place of formalin solution. Supernatant aliquots (10 pL) were added to 500 pL of 0.1% formic acid in acetonitrile for MS analysis. Positive ion electrospray spectra recorded in MS, MS 2, and MS 3 modes were used to confirm the presence of methylated MDMA. Liver tissue containing added MDMA HCI but not treated with formalin did not show a detectable level of methylated MDMA.
Introduction
Pharmacologically active amphetamine-related drugs are often implicated in forensic toxicology cases because of their abuse potential. Identification of substituted amphetamines can be hindered by the presence of formaldehyde as encountered in evidence obtained postembalming or after tissue fixation. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a structural analogue of methamphetamine. In the presence of formaldehyde, the active ingredient in most currently used embalming fluids, methamphetamine is methy]ated forming N,N-dimethylamphetamine (1) in a reaction well-described for a number of primary and secondary amine-containing drugs (1) (2) (3) (4) (5) (6) (7) (8) . In order to evaluate the reactivity of formaldehyde with MDMA, aqueous formaldehyde solution was incubated with MDMA HCI.
Experimental

Materials
MDMA HC1 and 3,4-methylenedioxyamphetamine (MDA) HCI were purchased from Sigma Chemical (St. Louis, MO). Formic acid, acetonitrile (HPLC optima grade), and formalin solution (37% w/w, A.C.S. grade) were purchased from Fisher Scientific (Pittsburgh, PA). All other chemicals were of the highest quality available and obtained from commercial sources.
Synthesis of 3,4-methylenedioxy-N,N-dimethylamphetamine (MDDA)
Following the method used by Tirumalai et al. (1) for the synthesis of N-methylmethamphetamine, formalin (37% formaldehyde, 0.4 mL), sodium cyanoborohydride (3 mg, 0.047 mmol), and sufficient glacial acetic acid to adjust the pH to 6.0 were added to a stirred suspension of MDMA HCl (5 rag, 0.025 mmol) in 3.0 mL acetonitrile. The pH of the reaction mixture was checked every 30 min, and glacial acetic acid was added as necessary to maintain the pH at 6.0. After a constant pH was achieved, the mixture was stirred overnight. After quenching by the addition of 3.0 mL of water, sufficient solid NaOH was added to render the mixture strongly alkaline (pH 12-14). The mixture was then extracted with n-hexane (2 x 6 mL), the combined organic extracts were dried (MgSO4) and filtered, and the volatile solvents were removed in a stream of air to yield MDDA (3.5 mg, 70% yield): mass spectrometry (MS), m/z 208, MH §
Reaction of MDMA HCI and formalin in human liver in vitro
The total analysis time starting from frozen samples was about 60 rain. MDMA HC1 (2 mg) in water (2 mL) was injected into the approximated center of randomly chosen pieces of human liver (100-200 rag). The liver pieces were placed in 200
IlL of 20% (v/v) unbuffered formalin solution or 200 pL of deionized water at room temperature in 1.5-mL polypropylene microcentrifuge tubes. The volume of formalin covered the tissue. The sample tubes were vortex mixed for 30 s and held at room temperature for 24 h. The samples were then homogenized and sonicated for 5 min and centrifuged at 13,000 rpm for 5 min. The pH of the supernatant of formalin-treated samples and water controls was measured with pH strips (pHydrion) and was in the range of 5.5-5.7. Supernatant aliquots (10 IlL) were added to 500 I~L of 0.1% formic acid in acetonitrile and mixed for mass spectral analyses. As a negative control, human liver pieces (100-200 mg) obtained from a case in which MDDA was screened for but not detected were prepared as described. The limit of detection with a signal/noise ratio of greater than 10 for all ions detected for MDMA and MDDA was approximately 0.7 pg/100 mg of tissue.
MS
Samples were directly infused at a flow rate of 10 IJL/min into an ion trap MS operating with an electrospray ionization source and positive ionization mode. The heated capillary temperature (MS 3) were generated over a 2 ainu mass range window centered on the parent mass ion with collision energy 25% of maximum.
Results
Under formaldehyde treatment at room temperature, MDMA was extensively methylated within 24 h to yield MDDA. The structure of MDDA derived from MDMA was assigned using electrospray ionization MS (Table I ). The reaction also occurred readily when MDMA HCI embedded in human liver was allowed to stand at room temperature in formalin solution (20% aqueous formaldehyde). As early as 30 rain in formalin solution, MDDA was detected by MS, and by 24 h, approximately 10% of unreacted MDMA remained unchanged. Figures I and 2 show the multistage mass spectra of the synthesized MDDA and the product isolated from the liver samples containing MDMA HC1 that were treated with formalin at room temperature for 24 h.
Multistage MS of the decomposed product of MDDA provided further confirmation of the product. The protonated molecular ion at m/z 208 was fragmented (MS-MS) to give ion m/z 163, which was further fragmented (MS-MS-MS) to give m/z 135 and 133. Table I lists 
Discussion
The decomposition of MDMA in the presence of formalin likely proceeds by the Eschweiler-Clarke reaction (9) shown in Scheme 1, which involves the reductive methylation of either primary or secondary amines in formaldehyde/formic acid mixtures. In the case of formalin solutions, it is likely that there is a sufficient amount of formic acid present as a contaminant to serve as a hydride source to reduce an imine intermediate.
Conclusions
Forensic toxicologists are cautioned that MDMA concentrations in formalin-fixed tissue may be diminished as a result of methylation of MDMA. Identification of both MDMA and MDDA in formalin-fixed samples may provide a better indicator of the presence of MDMA.
